Publication | Closed Access

Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome

Single-dose Crispr–cas9 TherapyNatural SciencesImmunologyGenetic EngineeringGene EditingGenome EngineeringGenome EditingGene ExpressionMedicineCell BiologyCrispr